Coinfection with chlamydia and gonorrhoea among pregnant women and bacterial vaginosis.

Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Coinfection with chlamydia and gonorrhoea among pregnant women and bacterial vaginosis.

Int J STD AIDS. 1996 Jan-Feb;7(1):61-4. Unique Identifier : AIDSLINE MED/96228430
Joesoef MR; Wiknjosastro G; Norojono W; Sumampouw H; Linnan M; Hansell MJ; Hillis SE; Lewis J; Division of STDHIV Prevention, Centers for Disease Control and; Prevention, Atlanta, Georgia, USA.

Abstract: The role of sexual transmission of microorganisms in bacterial vaginosis (BV) is controversial. If sexual intercourse were a risk factor for BV, then we would expect that women with BV would also be coinfected with other sexually transmitted diseases (STD). We investigated the prevalence of STD among pregnant women a low socio-economic status with bacterial vaginosis in Indonesia. Among these women, 23.3% had at least one STD (chlamydia, gonorrhoea, syphilis or trichomoniasis). Chlamydial infection was the most prevalent (19.5%), followed by trichomoniasis (3.8%), gonorrhoea (3.2%) and syphilis (0.4%). Compared to the rates of STD observed in a previous study of all pregnant women (with or without BV) in Indonesia, pregnant women with BV have more than a 2-fold increase in chlamydia (19.5% vs 8.2%) and a 6-fold increase in gonorrhoea (3.2% vs 0.5%). Because detection of BV by Gram stain is easy to perform and economical, detection of BV has potential as a prescreening marker for chlamydia and gonorrhoea among asymptomatic pregnant women of low socio-economic status in Indonesia. Further work is needed to evaluate the usefulness of BV as a prescreening marker for chlamydia and gonorrhoea.

Keywords: Adult Comorbidity Female Human Indonesia/EPIDEMIOLOGY Mass Screening Population Surveillance Poverty Pregnancy Pregnancy Complications, Infectious/*EPIDEMIOLOGY Prevalence Sexually Transmitted Diseases/*EPIDEMIOLOGY/MICROBIOLOGY/ TRANSMISSION Socioeconomic Factors Support, Non-U.S. Gov't Support, U.S. Gov't, Non-P.H.S. Vaginosis, Bacterial/*EPIDEMIOLOGY/TRANSMISSION JOURNAL ARTICLE
961030
M96A1429

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .